Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Buy
7,655
+93
+1% +$19.3K ﹤0.01% 734
2026
Q1
$1.7M Sell
7,562
-630
-8% -$157K 0.01% 652
2025
Q4
$1.97M Buy
8,192
+861
+12% +$220K 0.01% 633
2025
Q3
$2.01M Sell
7,331
-1,692
-19% -$462K 0.01% 587
2025
Q2
$2.33M Sell
9,023
-17
-0.2% -$4.05K 0.01% 582
2025
Q1
$2.02M Sell
9,040
-1,140
-11% -$266K 0.01% 601
2024
Q4
$2.33M Sell
10,180
-557
-5% -$134K 0.01% 616
2024
Q3
$2.62M Buy
10,737
+462
+4% +$103K 0.01% 593
2024
Q2
$1.97M Buy
10,275
+10
+0.1% +$2.03K 0.01% 656
2024
Q1
$2.03M Sell
10,265
-293
-3% -$53.7K 0.01% 655
2023
Q4
$1.82M Sell
10,558
-103
-1% -$15.8K 0.01% 672
2023
Q3
$1.58M Sell
10,661
-14,826
-58% -$2.68M 0.01% 689
2023
Q2
$5.57M Sell
25,487
-652
-2% -$145K 0.02% 398
2023
Q1
$5.72M Sell
26,139
-9,201
-26% -$2M 0.02% 392
2022
Q4
$7.36M Sell
35,340
-1,161
-3% -$255K 0.03% 354
2022
Q3
$7.97M Sell
36,501
-5,018
-12% -$1.14M 0.04% 322
2022
Q2
$8.57M Buy
41,519
+2,282
+6% +$486K 0.04% 289
2022
Q1
$9.52M Buy
39,237
+483
+1% +$117K 0.04% 273
2021
Q4
$10.1M Sell
38,754
-1,263
-3% -$328K 0.04% 273
2021
Q3
$10.5M Sell
40,017
-1,114
-3% -$305K 0.05% 254
2021
Q2
$10.1M Sell
41,131
-1,159
-3% -$244K 0.04% 266
2021
Q1
$8.2M Sell
42,290
-2,311
-5% -$463K 0.04% 295
2020
Q4
$9.48M Sell
44,601
-514
-1% -$102K 0.04% 265
2020
Q3
$7.73M Buy
45,115
+165
+0.4% +$30.5K 0.04% 278
2020
Q2
$8.63M Sell
44,950
-386
-0.9% -$63.2K 0.05% 248
2020
Q1
$6.68M Sell
45,336
-2,084
-4% -$332K 0.04% 294
2019
Q4
$7.35M Buy
47,420
+4,252
+10% +$613K 0.03% 234
2019
Q3
$5.83M Buy
43,168
+1,018
+2% +$133K 0.03% 309
2019
Q2
$5.14M Buy
42,150
+4,616
+12% +$511K 0.03% 323
2019
Q1
$3.9M Buy
37,534
+3,145
+9% +$325K 0.02% 367
2018
Q4
$3.92M Buy
34,389
+22,749
+195% +$2.44M 0.02% 350
2018
Q3
$1.34M Sell
11,640
-1,145
-9% -$125K 0.01% 659
2018
Q2
$1.32M Sell
12,785
-194
-1% -$19.6K 0.01% 670
2018
Q1
$1.28M Buy
12,979
+71
+0.6% +$6.71K 0.01% 676
2017
Q4
$1.09M Buy
12,908
+15
+0.1% +$1.24K 0.01% 736
2017
Q3
$992K Buy
12,893
+68
+0.5% +$5.2K 0.01% 748
2017
Q2
$998K Sell
12,825
-1,525
-11% -$109K 0.01% 743
2017
Q1
$1.03M Sell
14,350
-918
-6% -$63.4K 0.01% 744
2016
Q4
$947K Buy
15,268
+1,105
+8% +$67.7K 0.01% 779
2016
Q3
$919K Sell
14,163
-1,668
-11% -$111K 0.01% 814
2016
Q2
$1M Sell
15,831
-235
-1% -$13.9K 0.01% 774
2016
Q1
$929K Buy
16,066
+3,337
+26% +$189K 0.01% 804
2015
Q4
$683K Buy
12,729
+505
+4% +$28.5K ﹤0.01% 950
2015
Q3
$623K Sell
12,224
-47,883
-80% -$2.58M ﹤0.01% 984
2015
Q2
$3.39M Sell
60,107
-43,018
-42% -$2.72M 0.02% 465
2015
Q1
$7.4M Sell
103,125
-29,485
-22% -$1.92M 0.05% 288
2014
Q4
$7.43M Sell
132,610
-27,573
-17% -$1.44M 0.05% 289
2014
Q3
$7.89M Buy
160,183
+141,245
+746% +$7.19M 0.05% 274
2014
Q2
$958K Buy
18,938
+939
+5% +$46.5K 0.04% 305
2014
Q1
$805K Sell
17,999
-344
-2% -$15.5K 0.03% 317
2013
Q4
$864K Sell
18,343
-3,753
-17% -$190K 0.04% 299
2013
Q3
$1.17M Sell
22,096
-3,918
-15% -$190K 0.06% 228
2013
Q2
$1.18M Buy
+26,014
New +$1.23M 0.06% 231

Other funds holding RMD

M&T Bank's RMD Position: Q2 2026 in Review

M&T Bank increased its ResMed (RMD) stake by 1.2% in Q2 2026, buying an estimated $19.3K and bringing the position to 7,655 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #734.

M&T Bank first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.5M in Q3 2021. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • M&T Bank held 7,655 shares of ResMed worth $1.49M as of Q2 2026.
  • M&T Bank bought 93 ResMed shares in Q2 2026, an estimated $19.3K.
  • ResMed made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #734 holding.
  • M&T Bank first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • M&T Bank's ResMed position peaked at $10.5M in Q3 2021.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.